TrialThe British journal of ophthalmology2020

Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study.

Francesco Bandello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.